Ferritin levels and their association with regional brain volumes in Tourette's syndrome

American Journal of Psychiatry

Volumn 163, Issue 7, 2006, Pages 1264-1272

  Gorman, Daniel A ^a   Zhu, Hongtu ^b   Anderson, George M ^b   Davies, Mark ^b   Peterson, Bradley S ^b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; FERRIC CHLORIDE; FERRITIN; IRON; NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; DOPAMINE;

ADOLESCENT; ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; BASAL GANGLION; BRAIN CORTEX; BRAIN SIZE; CHILD; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; DOPAMINERGIC SYSTEM; FEMALE; GILLES DE LA TOURETTE SYNDROME; GRAY MATTER; HUMAN; HYPERACTIVITY; IRON BLOOD LEVEL; IRON DEFICIENCY; IRON METABOLISM; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING; NEUROTRANSMISSION; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSESSIVE COMPULSIVE DISORDER; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RATING SCALE; TIC; AGE; BLOOD; BRAIN; CAUDATE NUCLEUS; COMPARATIVE STUDY; HOSPITALIZATION; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; SEX DIFFERENCE; STATISTICS; SYNAPTIC TRANSMISSION;

ADOLESCENT; ADULT; AGE FACTORS; BASAL GANGLIA; BRAIN; CAUDATE NUCLEUS; CEREBRAL CORTEX; CHILD; DOPAMINE; FEMALE; FERRITINS; HUMANS; IRON; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SYNAPTIC TRANSMISSION; TOURETTE SYNDROME;

EID: 85047695664     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/ajp.2006.163.7.1264     Document Type: Article

References (54)

1. Peterson BS: Neuroimaging studies of Tourette syndrome: a decade of progress. Adv Neurol 2001; 85:179-196
2. 2 receptor binding. Science 1996; 273:1225-1227
3. Ernst M, Zametkin AJ, Jons PH, Matochik JA, Pascualvaca D, Cohen RM: High presynaptic dopaminergic activity in children with Tourette's disorder. J Am Acad Child Adolesc Psychiatry 1999; 38:86-94
4. Pinero D, Connor JR: Iron in the brain: an important contributor in normal and diseased states. Neuroscientist 2000; 6:435-453
5. Hill JM: The distribution of iron in the brain, in Brain Iron: Neurochemistry and Behavioral Aspects. Edited by Youdim MB. London, Taylor & Francis, 1988, pp 1-24
6. Hallgren B, Sourander P: The effect of age on the non-haemin iron in the human brain. J Neurochem 1958; 3:41-51
7. Beard JL, Connor JR: Iron status and neural functioning. Annu Rev Nutr 2003; 23:41-58
8. Sachdev P: The neuropsychiatry of brain iron. J Neuropsychiatry Clin Neurosci 1993; 5:18-29
9. Beard J: Iron deficiency alters brain development and functioning. J Nutr 2003; 133(1 suppl):1468S-1472S
10. Ben-Shachar D, Ashkenazi R, Youdim MB: Long-term consequence of early iron-deficiency on dopaminergic neurotransmission in rats. Int J Dev Neurosci 1986; 4:81-88
11. Lozoff B, Jimenez E, Hagen J, Mollen E, Wolf AW: Poorer behavioral and developmental outcome more than 10 years after treatment for iron deficiency in infancy. Pediatrics 2000; 105(4):e51
12. Brown KW, Glen SE, White T: Low serum iron status and akathisia. Lancet 1987; 1:1234-1236
13. Barton A, Bowie J, Ebmeier K: Low plasma iron status and akathisia. J Neurol Neurosurg Psychiatry 1990; 53:671-674
14. Crowe A, Morgan EH: Iron and transferrin uptake by brain and cerebrospinal fluid in the rat. Brain Res 1992; 592:8-16
15. 3 uptake. J Neurochem 1994; 62:1112-1118
16. Youdim MB, Ben-Shachar D, Yehuda S: Putative biological mechanisms of the effect of iron deficiency on brain biochemistry and behavior. Am J Clin Nutr 1989; 50:607-617
17. Earley CJ, Connor JR, Beard JL, Malecki EA, Epstein DK, Allen RP: Abnormalities in CSF concentrations of ferritin and transferrin in restless legs syndrome. Neurology 2000; 54:1698-1700
18. Berg D, Hoggenmuller U, Hofmann E, Fischer R, Kraus M, Scheurlen M, Becker G: The basal ganglia in haemochromatosis. Neuroradiology 2000; 42:9-13
19. Nielsen JE, Jensen LN, Krabbe K: Hereditary haemochromatosis: a case of iron accumulation in the basal ganglia associated with a parkinsonian syndrome. J Neurol Neurosurg Psychiatry 1995; 59:318-321
20. Moos T, Trinder D, Morgan EH: Cellular distribution of ferric iron, ferritin, transferrin and divalent metal transporter 1 (DMT1) in substantia nigra and basal ganglia of normal and beta2-microglobulin deficient mouse brain. Cell Mol Biol 2000; 46:549-561
21. O'Keeffe ST, Gavin K, Lavan JN: Iron status and restless legs syndrome in the elderly. Age Ageing 1994; 23:200-203
22. Ekbom KA: Restless legs syndrome. Neurology 1960; 10:868-873
23. Logroscino G, Marder K, Graziano J, Freyer G, Slavkovich V, Lolacono N, Cote L, Mayeux R: Altered systemic iron metabolism in Parkinson's disease. Neurology 1997; 49:714-717
24. Konofal E, Lecendreux M, Arnulf I, Mouren MC: Iron deficiency in children with attention-deficit/hyperactivity disorder. Arch Pediatr Adolesc Med 2004; 158:1113-1115
25. Wirshing DA, Bartzokis G, Pierre JM, Wirshing WC, Sun A, Tishler TA, Marder SR: Tardive dyskinesia and serum iron indices. Biol Psychiatry 1998; 44:493-498
26. Nemes ZC, Rotrosen J, Angrist B, Peselow E, Schoentag R: Serum iron levels and akathisia. Biol Psychiatry 1991; 29:411-413
27. Torsdottir G, Kristinsson J, Sveinbjornsdottir S, Snaedal J, Johannesson T: Copper, ceruloplasmin, superoxide dismutase and iron parameters in Parkinson's disease. Pharmacol Toxicol 1999; 85:239-243
28. Sachdev P: Tardive akathisia, tardive dyskinesia, and serum iron status. J Clin Psychopharmacol 1994; 14:147-149
29. Berger K, von Eckardstein A, Trenkwalder C, Rothdach A, Junker R, Weiland SK: Iron metabolism and the risk of restless legs syndrome in an elderly general population - the MEMO-study. J Neurol 2002; 249:1195-1199
30. Millichap JG, Yee MM, Davidson SI: Serum ferritin in children with attention-deficit hyperactivity disorder. Pediatr Neurol 2006; 34:200-203
31. Lammi-Keefe CJ, Lickteig ES, Ahluwalia N, Haley NR: Day-to-day variation in iron status indexes is similar for most measures in elderly women with and without rheumatoid arthritis. J Am Diet Assoc 1996; 96:247-251
32. Dale JC, Burritt MF, Zinsmeister AR: Diurnal variation of serum iron, iron-binding capacity, transferrin saturation, and ferritin levels. Am J Clin Pathol 2002; 117:802-808
33. Worwood M: Serum ferritin. CRC Crit Rev Clin Lab Sci 1979; 10:171-204
34. Cook JD, Lipschitz DA, Miles LE, Finch CA: Serum ferritin as a measure of iron stores in normal subjects. Am J Clin Nutr 1974; 27:681-687
35. 2 relaxation time asymmetries in Tourette's syndrome. Psychiatry Res 1994; 55:205-221
36. Pauls DL, Hurst CR: Schedule for Tourette and Other Behavioral Syndromes. New Haven, Conn, Yale University Child Study Center, 1996
37. Leckman JF, Riddle MA, Hardin MT, Ort SI, Swartz KL, Stevenson J, Cohen J: The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity. J Am Acad Child Adolesc Psychiatry 1989; 28:566-573
38. Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, Heninger GR, Charney DS: The Yale-Brown Obsessive Compulsive Scale, I: development, use, and reliability. Arch Gen Psychiatry 1989; 46:1006-1011
39. DuPaul GJ: Parent and teacher ratings of ADHD symptoms: psychometric properties in a community-based sample. J Clin Child Psychol 1991; 20:245-253
40. Kaufman AS, Kaufman NL: KBIT-2: Kaufman Brief Intelligence Test, 2nd ed. Circle Pines, Minn, American Guidance Service, 2004
41. Peterson BS, Staib L, Scahill L, Zhang H, Anderson C, Leckman JF, Cohen DJ, Gore JC, Albert J, Webster R: Regional brain and ventricular volumes in Tourette syndrome. Arch Gen Psychiatry 2001; 58:427-440
42. Peterson BS, Thomas P, Kane MJ, Scahill L, Zhang Z, Bronen R, King R, Leckman JF, Staib L: Basal ganglia volumes in patients with Gilles de la Tourette syndrome. Arch Gen Psychiatry 2003; 60:415-424
43. Shrout PE, Fleiss JL: Intraclass correlations: uses in assessing rater reliability. Psychol Bull 1979; 86:420-428
44. Baynes RD: Assessment of iron status. Clin Biochem 1996; 29:209-215
45. Custer EM, Finch CA, Sobel RE, Zettner A: Population norms for serum ferritin. J Lab Clin Med 1995; 126:88-94
46. Yip R, Johnson C, Dallman PR: Age-related changes in laboratory values used in the diagnosis of anemia and iron deficiency. Am J Clin Nutr 1984; 39:427-436
47. Curtis AR, Fey C, Morris CM, Bindoff LA, Ince PG, Chinnery PF, Coulthard A, Jackson MJ, Jackson AP, McHale DP, Hay D, Barker WA, Markham AF, Bates D, Curtis A, Burn J: Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease. Nat Genet 2001; 28:350-354
48. Ross EM: Evaluation and treatment of iron deficiency in adults. Nutr Clin Care 2002; 5:220-224
49. 2 receptors in rat brain. Pharmacol Biochem Behav 2001; 69:409-418
50. Csernansky JG, Csernansky CA, Bonnet KA, Hollister LE: Dopaminergic supersensitivity follows ferric chloride-induced limbic seizures. Biol Psychiatry 1985; 20:723-733
51. Spessot AL, Peterson BS: Tourette's syndrome: a multifactorial, developmental psychopathology, in Developmental Psychopathology, vol 2: Developmental Neuroscience, 2nd ed. Edited by Cicchetti D, Cohen DJ. New York, John Wiley & Sons, 2006
52. Sever Y, Ashkenazi A, Tyano S, Weizman A: Iron treatment in children with attention deficit hyperactivity disorder: a preliminary report. Neuropsychobiology 1997; 35:178-180
53. Schenck JF, Zimmerman EA: High-field magnetic resonance imaging of brain iron: birth of a biomarker? NMR Biomed 2004; 17:433-445
54. Hikita T, Abe K, Sakoda S, Tanaka H, Murase K, Fujita N: Determination of transverse relaxation rate for estimating iron deposits in central nervous system. Neurosci Res 2005; 51:67-71